SCLC	Small cell lung cancer
ES-SCLC	extensive-stage SCLC
PE	platinum-etoposide
TMB	Tumor Mutational Burden
Rb1	retinoblastoma1
DDR	DNA damage response
CHK1	checkpoint kinase 1
ATR	ataxia telangiectasia and RAD3-related protein
ATM	ataxia telangiectasia mutated
AURK	aurora kinase
EZH2	enhancer of zeste homology 2
LSD1	lysine-specific demethylase 1A
DLL3	delta-like ligand-3
SSTR2	somatostatin receptor 2
TAZ	transcriptional coactivator with PDZ-binding motif
PD-L1	Programmed death ligand-1
BTK	Bruton Tyrosine Kinase
BTKi	Bruton Tyrosine Kinase inhibition
CPS	PD-L1 combined positive score
MSI	Micro-Satellite Instability
bTMB	blood-based tumor mutational burden
MMR	Mismatch repair
SLFN11	protein Schlafen 11
CPIs	check point inhibitors
PCI	prophylactic cranial irradiation
ORR	overall response rate
mPFS	median progression free survival
HR	hazard ration
CI	confidence interval
mOS	median overall survival
OS	overall survival
irBORR	best immune related ORR